Kinetic Investments
Kinetic Investments
Send Message
Kinetic Investments
Stop FollowingKinetic Investments
View as an RSS Feed
View Kinetic Investments' Articles BY TICKER:
- MannKind: A Long and Costly Road Ahead
- Avanir Pharmaceuticals' Possible and Unofficial Sales Guidance Is Good for Long-Term Investors
- GTx Roaring Into Earnings: Potential Short-Term Momentum Play
- Spectrum Pharma: Yet Another Bio Flash Crash Ahead of an FDA Decision
- Dendreon's Q1 Earnings Preview: Meet, Beat, or Miss?
- Jazz Pharmaceuticals: Another Healthcare Sector Flash Crash, Stop-Limits Triggered
- Avanir Pharma Begins to Demonstrate Its Relevance; Shares Surge on Heavy Volume
- Zalicus: Is Wall Street Wise to Its Long-Term Potential?
- Amylin: Diabetes Drug Bydureon Closer to EU Approval
- Amarin: Market Seems to Be Anticipating Positive ANCHOR Trial Data
- Exelixis: Preparing to be Purchased?
- Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
- XenoPort: Waiting for the Post-Approval Dust to Settle
- Star Scientific's Stock Is Smoking: Will Shares Come Down to Earth?
- Dendreon: Mammoth Potential Despite Drama
- FDA Insider Trading: Time for an Overhaul?
- Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part II
- Avanir Pharmaceuticals: Uncovering Nuedexta's Potential Part I
- Atmel: Recent Market Pullback Presents an Opportunity
- Ariad Pharmaceuticals: Solid Company but Not a Steal
- Star Scientific: A Struggling Tobacco Company Sitting on a Healthcare Gold Mine?
- Avanir Pharmaceuticals: Full Steam Ahead
- Will Netflix Continue to Stream Gains Into Your Portfolio in 2011?
- Could Avanir Pharmaceuticals Become a 2011 Takeover Target?
- Somaxon Pharmaceuticals: Will FDA Approval Ever Pay Off?
- Mannkind: Of Bio Flash Crashes and Stop Limits
- The Market Seems to Disagree With Alexza's Promising News
- How Much Upside Potential Does Atmel Still Have?
- Avanir Pharmaceuticals Poised for a Strong New Drug Launch
